ArticleUpdates in surgery2026
The WPG score for predicting clinically relevant postoperative pancreatic fistula after Wirsung-pancreatogastrostomy.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinically relevant postoperative pancreatic fistula (CR-POPF) remains a major cause of morbidity after pancreaticoduodenectomy (PD). Most available prediction models were developed for pancreatojejunostomy (PJ), limiting their accuracy for Wirsung pancreatogastrostomy (WPG). This study developed and internally assessed a WPG-specific risk score (WPG Score) for predicting CR-POPF after PD. This bicentric retrospective study included 345 patients undergoing PD with WPG between 2014 and 2024 at two Italian high-volume centers. Independent predictors of CR-POPF (ISGPS grade B/C) were identified using multivariable logistic regression and incorporated into the WPG Score. Predictive accuracy was assessed through ROC analysis and compared with the original Fistula Risk Score (FRS) and the alternative FRS (a-FRS). Male sex (OR 3.81), BMI ≥ 25 (OR 3.02), and soft pancreatic texture (OR 4.40) were independently associated with CR-POPF. Ampullary/biliary pathology was retained in the final predictive model based on the pre-specified stepwise retention criterion and its biological plausibility. The WPG Score (0-6 points) stratified patients into low- (3.7%), intermediate- (18.9%), and high-risk groups (51.7%) (p < 0.0001). Apparent discrimination was good (AUC 0.779), with an optimism-corrected AUC of 0.757 on bootstrap internal validation. The model showed good calibration (Hosmer-Lemeshow p = 0.876; Brier score 0.118). Discriminative performance was superior to both FRS (AUC 0.779 vs. 0.613) and a-FRS (AUC 0.779 vs. 0.649) (p = 0.002). The WPG Score provides the first anastomosis-specific tool for predicting clinically relevant postoperative pancreatic fistula after pancreatogastrostomy. Although external validation is still required, the score demonstrated promising discriminative performance in this bicentric cohort.
Indexed as
Identifiers
42334809What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.